Suppr超能文献

肠道微生物群调节了补充索氏厌氧丁酸杆菌对小鼠葡萄糖稳态的影响。

The gut microbiome modulates the impact of Anaerobutyricum soehngenii supplementation on glucose homeostasis in mice.

作者信息

Hutchison Evan R, Yen Mei-I, Peng Hubert W, Davis Chris R, Vivas Eugenio I, Tallon Michael M, Bui Thi Phuong Nam, de Vos Willem M, Yen C-L Eric, Nieuwdorp Max, Rey Federico E

机构信息

University of Wisconsin-Madison.

Wageningen University.

出版信息

Res Sq. 2024 May 2:rs.3.rs-4324489. doi: 10.21203/rs.3.rs-4324489/v1.

Abstract

BACKGROUND

There is growing interest in the development of next-generation probiotics to prevent or treat metabolic syndrome. Previous studies suggested that may represent a promising probiotic candidate. A recent human study showed that while supplementation is well tolerated and safe, it resulted in variable responses among individuals with a subset of the subjects significantly benefiting from the treatment. We hypothesized that gut microbiome variation is linked to the heterogeneous responses to treatment observed in humans.

RESULTS

We colonized germ-free mice with fecal microbiota from human subjects that responded to treatment (R65 and R55) and non-responder subjects (N96 and N40). Colonized mice were fed a high-fat diet (45% kcal from fat) to induce insulin resistance, and orally treated with either live culture or heat-killed culture. We found that R65-colonized mice received a benefit in glycemic control with live treatment while mice colonized with microbiota from the other donors did not. The glucose homeostasis improvements observed in R65-colonized mice were positively correlated with levels of cecal propionate, an association that was reversed in N40-colonized mice. To test whether the microbiome modulates the effects of propionate, R65- or N40-colonized mice were treated with tripropionin (TP, glycerol tripropionate), a pro-drug of propionate, or glycerol (control). TP supplementation showed a similar response pattern as that observed in live treatment, suggesting that propionate may mediate the effects of . We also found that TP supplementation to conventional mice reduces adiposity, improves glycemic control, and reduces plasma insulin compared to control animals supplemented with glycerol.

CONCLUSIONS

These findings highlight the importance of the microbiome on glycemic control and underscore the need to better understand personal microbiome-by-therapeutic interactions to develop more effective treatment strategies.

摘要

背景

开发用于预防或治疗代谢综合征的下一代益生菌的兴趣日益浓厚。先前的研究表明,[具体内容缺失]可能是一种有前景的益生菌候选物。最近一项人体研究表明,虽然补充[具体内容缺失]耐受性良好且安全,但个体之间的反应存在差异,部分受试者从治疗中显著受益。我们假设肠道微生物群的变化与人类中观察到的对[具体内容缺失]治疗的异质性反应有关。

结果

我们用来自对[具体内容缺失]治疗有反应的人类受试者(R65和R55)和无反应受试者(N96和N40)的粪便微生物群对无菌小鼠进行定殖。给定殖的小鼠喂食高脂肪饮食(45%千卡来自脂肪)以诱导胰岛素抵抗,并口服活的[具体内容缺失]培养物或热灭活培养物。我们发现,用活的[具体内容缺失]治疗时,定殖了R65微生物群的小鼠在血糖控制方面受益,而定殖了其他供体微生物群的小鼠则没有。在定殖了R65微生物群的小鼠中观察到的葡萄糖稳态改善与盲肠丙酸水平呈正相关,在定殖了N40微生物群的小鼠中这种关联则相反。为了测试微生物群是否调节丙酸的作用,用丙酸前体药物三丙酸甘油酯(TP,甘油三丙酸酯)或甘油(对照)处理定殖了R65或N40微生物群的小鼠。补充TP显示出与活的[具体内容缺失]治疗中观察到的类似反应模式,表明丙酸可能介导[具体内容缺失]的作用。我们还发现,与补充甘油的对照动物相比,给常规小鼠补充TP可降低肥胖、改善血糖控制并降低血浆胰岛素水平。

结论

这些发现突出了微生物群对血糖控制的重要性,并强调需要更好地理解个体微生物群与治疗之间的相互作用,以制定更有效的治疗策略。

相似文献

7
Oral augments glycemic control in type 2 diabetes.口服药物可增强2型糖尿病患者的血糖控制。
iScience. 2024 Jul 5;27(8):110455. doi: 10.1016/j.isci.2024.110455. eCollection 2024 Aug 16.

本文引用的文献

4
Multivariable association discovery in population-scale meta-omics studies.基于人群的宏基因组学研究中的多变量关联发现。
PLoS Comput Biol. 2021 Nov 16;17(11):e1009442. doi: 10.1371/journal.pcbi.1009442. eCollection 2021 Nov.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验